chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Next morning woke up shaking chills; Feeling feverish but no fever; Arm sore immediately following shot; In evening body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration on 24Mar2021 at 11:30 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. Medical history included obese and blood pressure being monitored. The patient did not have any allergies to medications, food, or other products. Concomitant medication included multi-vitamin (MANUFACTURER UNKNOWN) for unspecified indication started from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 24Mar2021 at 12:00, the patient experienced arm sore immediately following the shot and in the evening the patient experienced body aches. On 25Mar2021 (next morning), the patient woke up with shaking chills and feeling feverish but no fever. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse events and included treatment with TYLENOL. The clinical outcome of the events pain in arm, general body pain, chills and feverish were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
HARD TIME TO SEE/VISION HAS GONE VERY LOW; LOST THOUSANDS OF HAIR/2/3 OF HAIR FALLING; SEVERE NUMBNESS IN TOES AND LEFT ARMS; VERY BAD REACTION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On SEP-2021, the patient experienced very bad reaction. On an unspecified date, the patient experienced hard time to see/vision has gone very low, lost thousands of hair/2/3 of hair falling, and severe numbness in toes and left arms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the very bad reaction, hard time to see/vision has gone very low, lost thousands of hair/2/3 of hair falling and severe numbness in toes and left arms was not reported. This report was non-serious.
Vaccination failure; Shingles; Loss of Bowel Function; Diarrhea; Off label use; This case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included diarrhea, intestinal functional disorder and shingles (internal shingles affected her intestines).   On an unknown date, the patient received the 1st dose of Shingrix, the 2nd dose of Shingrix and the 3rd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, intestinal functional disorder, diarrhea and drug prescribing error. On an unknown date, the outcome of the vaccination failure, shingles, intestinal functional disorder, diarrhea and drug prescribing error were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. It was unknown if the reporter considered the intestinal functional disorder and diarrhea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported for 1st and 2nd dose of Shingrix. The age at vaccination was not applicable for 3rd dose of Shingrix. The patient who has gotten two doses of Shingrix, and had a prescription for a third dose, which led to drug prescribing error.  The patient had complications from shingles where it has invaded her internal organs, and she was getting periodic symptoms even after her two standard doses of Shingrix. The patient's internal shingles affected her intestines, and she has experienced urgent diarrhea both during her initial outbreak (before the vaccine doses) and again now (approximately 7 months after her 2nd dose). In both cases she completely lost control of her bowels. The reporter consented for follow up.
Initial report received from a company representative, who received the original report from a health care professional on 20 September 2011. A male adolescent patient (date of birth 1994) with no reported medical history had received a dose of FLUZONE (lot number UH467AB) from a multi dose vial on an unspecified date. An unspecified amount of time after vaccination the patient called the pediatricians office to report throat swelling and numbness which was on a "Sunday" (18 September 2011) and subsequently went to the emergency department on 19 September 2011 and was admitted the following day (20 September 2011). Treatments received and diagnostic tests performed were not reported. Recovery status was not reported. Documents held by sender: None.
Information has been received from a physician concerning a patient who in 1999 was vaccinated with a 0.5 mL dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). On approximately 15-JUN-2006, the patient developed mumps. The patient was seen in the office on 15-JUN-2006. Blood tests were performed, results not reported. At the time of the report the patient had not yet recovered. There was no product quality complaint involved. Follow-up information indicated that the patient did not have mumps. The patient developed "something" that resulted in a doctors visit and required blood work. Additional information has been requested.
Information has been received from a registered nurse (also reported as nurse practitioner) concerning a 15 year old female patient with bipolar disorder and no known drug allergy who on 26-OCT-2010 was vaccinated with the third 0.5 ml dose of GARDASIL (lot number 666595/0096Z) at a center after school. Patient had eaten both breakfast and lunch, but had experienced heart palpitations at school and was sent to the school nurse. Vital signs were stable right before the vaccine was given at the center. Concomitant medications included: DEPO-PROVERA and cabbage palm (manufacturer unknown) for weight control. Patient was vaccinated with the first and second dose of GARDASIL on 08-APR-2010 and 08-JUN-2010 and had no problems. Patient stated she felt light headed before she arrived at the office after school on 26-OCT-2010 and she had been taking diet pills. DEPO-PROVERA was not given on 26-OCT-2010. When the center was ready to inject the patient, the seizure started and lasted about one minute. Patient was taken to emergency room. By that time patient also had throat swelling. It was unknown what treatment was provided. Patient had another seizure in the emergency room. No hospital admission. Patient referred to her pediatrician. Event was not disabling or life threatening. Patient returned to school the next day with the present status recovering. Upon internal review, seizures were considered to be an other important medical event. Additional information has been requested.
Mother called and said the son had experienced chest pain and tightness and difficulty breathing the previous week.  advised mother to have patient seen by physician.
ADMINISTRATION ERROR : Patient was supposed to be receiving Flu shot, but instead received Covid (PFIZER) vaccination. Patient received FLU vaccination right afterwards in different arm. Patient was fully vaccinated at the time with MODERNA vaccination.
PATIENT HAD JOINT AND MUSCLE FATIGUE 2 DAYS AFTER THE INJECTION. NO OTHER CHANGES IN DIET, MEDICATION, OR HEALTH UNRELATED TO THE VACCINE. WAS BEDRIDDEN FOR 2 DAYS DUE TO THE BODY PAIN. STILL HAD SOME JOINT PAIN TODAY (5 DAYS POST INJECTION) BUT COULD GET OUT OF BED.
Mom said that her daughter really complained about the Gardasil being really painful when she got it. After mom stated that she developed a weird rash on her arm where the shot was given. That has resolved and there is no swelling now. Since then she has experienced pain going down her arm, to the point where mom says that she can't even move it due to pain. She is experiencing shooting pains in her 1-3 fingers fingers.
Intractable migraine; vertigo; irregular menstrual cycles afterwards; nausea; fatigue; low blood pressure; new muscle tightness in left shoulder and left neck; moderate anemia
Pain; severe muscle stiffness in my left hip leg; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Pain) and MUSCULOSKELETAL STIFFNESS (severe muscle stiffness in my left hip leg) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Pain) and MUSCULOSKELETAL STIFFNESS (severe muscle stiffness in my left hip leg). At the time of the report, PAIN (Pain) and MUSCULOSKELETAL STIFFNESS (severe muscle stiffness in my left hip leg) outcome was unknown.            Concomitant products used by the patient included Adelaide Foncha Treatment information was not provided
She had very similar symptoms as me; This spontaneous case was reported by an other health care professional and describes the occurrence of   in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lung cancer and COVID-19.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
11-7-09 3 1/2 hrs to 4 hrs after vaccine was having trouble getting her breath. Felt like an asthma attack. Went to ER but no treatment was necessary according to client. Arrived at ER @ 445 pm
Pt began to develop rash on extremeties, face, abdominal area within one hour of administration.
Shortness of breath; Very swollen and red rash; Swelling at the injection site; Itching at the injection site; Cramping; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MUSCLE SPASMS (Cramping), DYSPNOEA (Shortness of breath), RASH ERYTHEMATOUS (Very swollen and red rash), INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE PRURITUS (Itching at the injection site) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A027L20A) for COVID-19 vaccination.     Concurrent medical conditions included Lactose intolerance and Seafood allergy (scallops). Concomitant products included TRAMADOL HCL, OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), LORAZEPAM (ATIVAN) and SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM DS) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced MUSCLE SPASMS (Cramping). On 20-Jan-2021, the patient experienced INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE PRURITUS (Itching at the injection site). On 21-Jan-2021, the patient experienced DYSPNOEA (Shortness of breath) and RASH ERYTHEMATOUS (Very swollen and red rash). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Cramping), DYSPNOEA (Shortness of breath), RASH ERYTHEMATOUS (Very swollen and red rash), INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE PRURITUS (Itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
When I woke up this morning I felt nauseous, cold, very tired, and had serious body aches. As the day progressed, I continued to feel cold very tired,  had body aches and a heachache came on. My nausea turned into pain for the entire morning but was gone by 2:00 pm.
diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also pruritis on back abdomen arms and legs.; diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also pruritis on back abdomen arms and legs.; Mild scratchy throat; This is a spontaneous report from a contactable nurse (patient). A 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL3249), via an unspecified route of administration on 29Jan2021 13:15 at single dose (right arm) for COVID-19 immunization. Medical history included occasional gastric reflux and allergies. The patient was not pregnant. Patient had unspecified concomitant medications which was received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29Jan2021, at 20:00, the patient developed a diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also, pruritis on back abdomen arms and legs and mild scratchy throat. The patient noticed these symptoms several hours after injection and was worse on day 2. There was no treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of events was not recovered.
On 10/27/99, the pt experienced a series of seizures. The pt was evaluated and over the course of the next several weeks clearly developed a progressive encephalopathy which has resulted in her being hospitalized and for which the physician has no etiology.
That night after the vaccine, I began feeling nauseous. I didn't run a fever, but was feeling very sick to my stomach. The day after that, I woke up with a back ache. I was able to do my morning back exercises and go for a walk with a friend which seemed to help for a while but it then came back full force later that day. I do have a bulging disk in my lower back and have had multiple experiences with whip lash. I have seen chiropractors and orthopedic doctors in the past, but none of the episodes of back pain have lasted this long. The pain is particularly bad when sitting and has effected my walking and feels almost like it's in my hip area, but my medical professional relative has advised me that it sounds more like the problem is in my back.
PATIENT HAD DIFFICULTY SWALLOWING AND TONGUE BEGAN TO SWELL 30 MINUTES AFTER RECIEVING VACCINE. ADMINISTERED BENADRYL 25 MG LIQUID ORALLY AND HAD PATIENT GO TO HOSPITAL
Left thigh with circumferential swelling, anterior erythema, blanching. Knee edema, mild tenderness and warmth.
pt states she started having chills.  She took 2 extra strength Tylenol and some cough syrup w/ codeine.  She laid back in a recliner covered up with a blanket until the chills were gone.  The symptoms lasted about 12 hours. She no longer has any symptoms.
1225: Pt c/o dizzyness, light headed, Pulse 63, spo2 98% RA. EMT notified. Pt observed. Pt released at 1236
Body pain, headache, joint pain, (R) arm pain, fever 100.7.
Received first COVID-19 vaccine on 2/18/21. Tested positive for COVID-19 on 2/21/21.
Heart rate up to 204 within minutes of receiving the vaccine; heart rate fluctuated between 104-114 fifteen minutes later, eventually normalized after 30 minutes; severe lymph node inflamed under armpit the following day; dose number=3; dose number=3; This is a spontaneous report from a contactable consumer (patient).   A 38-years-old non-pregnant female patient received booster dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FF2587, expiration date not reported), via an unspecified route of administration, administered in right arm on 05Oct2021 17:00 (at the age of 38 years) as dose 3 (booster), single for COVID-19 immunization. Medical history included allergies to penicillin and sulfa from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient previously received first dose of bnt162b2 (Lot Number: EL3249) as dose 1, single and second dose of bnt162b2 (Lot number: EN9581) as dose 2 single, both via an unspecified route of administration on an unspecified date for COVID-19 immunization. Patient was not pregnant at the time of vaccination. No other vaccine in four weeks. No covid prior vaccination and not COVID tested post vaccination. On 05Oct2021 17:15, the patient experienced heart rate up to 204 within minutes of receiving the vaccine; heart rate fluctuated between 104-114 fifteen minutes later, and eventually normalized after 30 minutes. Patient also had severe lymph node inflamed under armpit the following day (same arm as injection site) on 05Oct2021 17:15. Events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for events was unknown. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
POTS, Kidney Stones, Chronic fatigue; still undergoing tests to determine all causes but she hasn't "been right" since the shot.
6/4 - Large red swollen site at injection site 3" x 4" went to hospital ER on 6/4/12. They said reaction to vaccine gave her Z pack & BENADRYL. 6/6 - Went back to ER now she said she has cellulitis.
About 2 hours after vaccines, took formulas feeding, had an episode of screaming 20-30 mins, pulled up legs, spit up, no bile, after spit up was very listless, seemed cold to touch and fell asleep. Slept a little longer than normal/out today 8/26/16. Is afebrile, alert, active, eating/sleeping well.
DONOR STATED ON 08/09/16 HER ARM FELT SORE, RED ITCHING AND COULD FEEL A BUMP. REPORTED THE INCIDENT ON 08/12/16. MINOR ITCHING, REDNESS (LOCALIZED), MINOR BUMP IN SITE AREA.
Had blood pressure spikes; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HYPERTENSION (Had blood pressure spikes) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (Had blood pressure spikes). At the time of the report, HYPERTENSION (Had blood pressure spikes) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medication were reported. No treatment information were provided.
Developed bilateral axillary lymphadenopathy 2 days post vaccination started having fever 3 days after vaccination. Worsening tenderness in axillary lymphadenopathy on day 5 post vaccination.
"No pain from needle but instant hot as medication dispensed. Within 10 minutes arm became sore. By nightfall, could not raise right arm above head. Dull ache - constant". Neck became stiff by 2nd night - very stiff by morning - seems to loosen up by morning (mid-am). Not sore to touch. "Used TYLENOL, rubbed area, stretched". 11-10-10 Right arm discomfort persists. Limited ability to raise right arm overhead. Poor sleeping ability due to pain rated 7-8 - uses anti-inflammatory meds. Use of warm moist compresses, anti-inflammatory meds, gentle stretching right arm encouraged.
pain, throbbing throughout the arm, burning at injection site and shoulder. took aleve for 48 hours, rested and iced arm.
Reports she suddenly felt ill the morning of January 22, chills, weak, fatigue. Followed by what appeared to be a Grand Mal Seizure. Reports she has not had a seizure in 20 years. However writer found documentation of a seizure in 2014. Patient feels it was related to the vaccine.
(L) upper arm with redness, swelling, some induration on lateral aspect with TTP. Tx: O.V.; BENADRYL 2 tsp po every 6 hrs x 48 hrs, then PRN. Return if s/s worsen or fever develops.
Shortness of Breath per Moderna Customer Care representative; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of Breath per Moderna Customer Care representative) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced DYSPNOEA (Shortness of Breath per Moderna Customer Care representative). At the time of the report, DYSPNOEA (Shortness of Breath per Moderna Customer Care representative) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Concomitant medications were not reported.
Patient had vaccination and placed in observation area. Patient had syncopal episode post vaccination. Was seen fall down and hit head and had seizure activity that lasted less than 10 seconds. Patient had brief postictal phase without loss of bladder or bowel control. After a few seconds patient was able to relay his name and was alert and oriented to time and place. Evaluated patient for bodily harm, after finding none moved patient to medical area. Took vital signs and called for transportation to hospital. Medical transport came and after evaluation asked to take patient to hospital patient refused transportation. Patient refused going to hospital and left AMA.   Of note, Patient has a history of syncope post injection that was failed to inform us. He mentioned he was afraid to needles like most patients report. Patient said it has happened before after flu shot along with syncope and seizures.
tested positive for covid; drug ineffective; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation .The patient medical history,concomitant medications were not reported.On an unspecified date The patient tested positive for covid (covid-19). The caller wanted to know if it was safe for her to get her second covid vaccine after she tested positive for covid after receiving her first covid vaccine.The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.